Soleno Therapeutics, Inc.
SLNO
$65.57
$2.834.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 286.84M | 289.95M | 291.44M | 256.78M | 266.12M |
| Total Receivables | 24.62M | -- | -- | -- | -- |
| Inventory | 2.36M | -- | -- | -- | -- |
| Prepaid Expenses | 2.97M | 5.87M | 2.45M | 1.42M | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 13.10M | -- | -- | -- |
| Total Current Assets | 316.79M | 308.92M | 293.89M | 258.20M | 267.50M |
|
|
|||||
| Total Current Assets | 316.79M | 308.92M | 293.89M | 258.20M | 267.50M |
| Net Property, Plant & Equipment | 2.60M | 2.78M | 2.98M | 3.19M | 287.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.83M | 6.32M | 6.81M | 7.29M | 7.78M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 83.00K | 83.00K | 83.00K | 83.00K | 83.00K |
| Total Assets | 332.31M | 318.09M | 330.97M | 296.71M | 304.13M |
|
|
|||||
| Total Accounts Payable | 6.22M | 5.48M | 8.88M | 6.24M | 3.72M |
| Total Accrued Expenses | 8.54M | 6.52M | 6.60M | 5.17M | 4.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 676.00K | 597.00K | 526.00K | 448.00K | 296.00K |
| Total Finance Division Other Current Liabilities | 5.51M | 3.13M | 2.74M | 3.10M | 1.13M |
| Total Other Current Liabilities | 5.51M | 3.13M | 2.74M | 3.10M | 1.13M |
| Total Current Liabilities | 20.94M | 15.73M | 18.75M | 14.96M | 9.15M |
|
|
|||||
| Total Current Liabilities | 20.94M | 15.73M | 18.75M | 14.96M | 9.15M |
| Long-Term Debt | 49.85M | 49.84M | 49.83M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.25M | 2.36M | 2.47M | 2.58M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.13M | 17.90M | 14.81M | 14.46M | 14.22M |
| Total Liabilities | 92.17M | 85.83M | 85.86M | 32.01M | 23.37M |
|
|
|||||
| Common Stock & APIC | 740.80M | 728.07M | 697.01M | 660.08M | 600.57M |
| Retained Earnings | -500.74M | -496.03M | -452.26M | -396.28M | -319.66M |
| Treasury Stock & Other | 85.00K | 226.00K | 361.00K | 895.00K | -153.00K |
| Total Common Equity | 240.14M | 232.26M | 245.11M | 264.70M | 280.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 240.14M | 232.26M | 245.11M | 264.70M | 280.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 240.14M | 232.26M | 245.11M | 264.70M | 280.76M |
|
|
|||||